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ABSTRACT
Objectives: Reliable reconciliation of medicines at
admission and discharge from hospital is key to
reducing unintentional prescribing discrepancies at
transitions of healthcare. We introduced a team
approach to the reconciliation process at an acute
hospital with the aim of improving the provision of
information and documentation of reliable medication
lists to enable clear, timely communications on
discharge.
Setting: An acute 400-bedded teaching hospital in
London, UK.
Participants: The effects of change were measured in
a simple random sample of 10 adult patients a week
on the acute admissions unit over 18 months.
Interventions: Quality improvement methods were
used throughout. Interventions included education and
training of staff involved at ward level and in the
pharmacy department, introduction of medication
documentation templates for electronic prescribing and
for communicating information on medicines in
discharge summaries co-designed with patient
representatives.
Results: Statistical process control analysis showed
reliable documentation (complete, verified and
intentional changes clarified) of current medication on
49.2% of patients’ discharge summaries. This appears
to have improved (to 85.2%) according to a poststudy
audit the year after the project end. Pharmacist
involvement in discharge reconciliation increased
significantly, and improvements in the numbers of
medicines prescribed in error, or omitted from the
discharge prescription, are demonstrated. Variation in
weekly measures is seen throughout but particularly at
periods of changeover of new doctors and introduction
of new systems.
Conclusions: New processes led to a sustained
increase in reconciled medications and, thereby, an
improvement in the number of patients discharged
from hospital with unintentional discrepancies (errors
or omissions) on their discharge prescription. The
initiatives were pharmacist-led but involved close
working and shared understanding about roles and
responsibilities between doctors, nurses, therapists,
patients and their carers.
INTRODUCTION
Transfers between interfaces of care, especially
discharge from acute hospital into the commu-
nity, are recognised as high-risk transitions
for the development of medicines-related
problems, a leading cause of morbidity and
mortality.1 Medication ‘continuity’ errors are
frequent, involving up to 70% of inpatients on
admission to hospital2 and contributing to
avoidable readmissions.3 Considering that
between 28% and 40% of medicines are dis-
continued or altered during hospitalisation,4
and fewer than 10% of elderly inpatients go
home on the same medication as on admis-
sion,5 accurate communication of changes at
discharge is an increasingly important contri-
bution to patient safety and quality of care.
Medicines reconciliation, the process of
identifying the most accurate list of a
patient’s medicines and comparing it with
Strengths and limitations of this study
▪ We recognised the importance of organisation
and structure in reducing unintended discrepan-
cies at transfer of care.
▪ We showed a critical relationship between dis-
charge summary quality and junior doctor rota-
tions. Interventions were specifically made at
these key times and appear to have had a posi-
tive effect on the numbers of patients with error-
free medication lists.
▪ Appropriate systems changes were embedded to
ensure sustainability.
▪ Limitations in our methodology meant we are
unable to show whether the decrease in errors
was directly related to introduction of
pharmacist-led discharge medicines reconcili-
ation or secular trends.
▪ We do not know if improvements in communica-
tions had any impact on patient outcomes post-
discharge from hospital.
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current prescribing, recognising any discrepancies and
documenting any changes, is essential for minimising
continuity errors.6 The elements of reliable reconcili-
ation are at each transition in care:
▸ veriﬁcation (of the list of current medications the
patient is actually taking);
▸ validation (acute review noting whether to continue,
alter doses, hold, or stop);
▸ clariﬁcation (comparing the medication list with
current prescription order).6
Increased pharmacist involvement at admission, docu-
mentation of changes, and systems facilitating transfer of
information from the general practitioner (GP) to hos-
pital, all appear to reduce medication error.7 Previous
local audit had revealed that though actively involved in
the timely resolution of discrepancies between patients’
medicines list from the GP and the hospital doctor,
there was a lack of discharge communication from hos-
pital pharmacists. In addition, the quantity and quality
of information on medication changes made during
hospitalisation was low; only one in 10 patients was dis-
charged from hospital with sufﬁcient information on
their discharge summaries to enable safe ongoing pre-
scribing. The information required was considered insuf-
ﬁcient if one or more medicines were omitted; a
stopped medicine was included erroneously or without
explanation; the dose, route, course length or formula-
tion (or change reason) was wrong or omitted; or essen-
tial monitoring information was lacking.
We recognised the need to integrate discharge recon-
ciliation into the processes involving ward pharmacists;
that is, in conﬁrming the clinical appropriateness of pre-
scribing during the inpatient stay and checking back to
the medicines history when organising take-home medi-
cines. Pharmacy-led reconciliation is considered a cost-
effective intervention.7
The overall aim of this study was to provide seamless,
high-quality medicines reconciliation from admission
through to discharge for all patients, and improve com-
munication with community service providers.
The objectives were to:
▸ reduce unintentional discrepancies in transcribing
medication during admission to hospital
▸ improve documentation of medicines reconciliation
at discharge
▸ improve the quality of communications regarding
new and intentional changes to medication in the
hospital discharge summary.
Ethical approval
Ethics approval was not required for this work, as it was
part of a service evaluation and improvement activity
and not human subjects research. An ethics waiver was
granted by Chelsea and Westminster Hospital NHS
foundation trust (CWH) Research and Development
lead.
METHODS
Setting
The main study was conducted at an acute hospital over
18 months, from September 2011 to March 2013. A post-
study audit to check whether any improvements have
been sustained was carried out during June to August
2014. The focus of the study was the Acute Assessment
Unit (AAU), a 44-bed adult ward seeing an average of
25 admissions a day with a mean age of ∼61 years. These
are predominantly medical patients (17% surgical
admissions) discharged home or to a longer stay ward
usually within 4 days. The average length of stay in hos-
pital was 9.3 days at the time of the study. Junior doctors
are responsible for documenting the patient’s history
on admission (including their medicines), prescribing
ongoing medication and preparing the discharge
summary. The pharmacist on AAU veriﬁes the medica-
tion history, validates and checks that all current con-
tinuing medicines are correctly prescribed on the
inpatient electronic prescribing system (ePR). If a dis-
crepancy is found, or a change is made without the
reason or indication documented as part of the medica-
tion order, it is clariﬁed by the pharmacist. The pre-
scriber is contacted to ascertain if the change was
intentional. The completion of this pharmacist-led
process of reliable reconciliation at admission is also
documented appropriately on the ePR. Discharge pre-
scribing is supported by pharmacists who check (or tran-
scribe) take-home medicines (TTO). When the hospital
has reduced capacity to admit to AAU, the focus for
medical teams shifts to support speedier discharge
including writing TTOs as early as possible. Early dis-
charge relieves the bed pressures and allows for admis-
sion of new patients. Pharmacist activity on AAU is not
usually affected by these changes and was maintained
throughout the project.
Planning the intervention
Following recognition of low overall numbers of patients
whose medicines are fully reconciled, a core team of phar-
macists and physicians convened with the objective of
improving rates locally. Quality improvement (QI) meth-
odologies were employed throughout.8 9 Workshops took
place at the start of the project to identify stakeholders
(see online supplementary appendix ﬁgure 1), and their
engagement was plotted on the matrix again at 15 months
(see online supplementary appendix ﬁgure 2). Process
mapping identiﬁed the various stages of medicines recon-
ciliation in the hospital (see online supplementary appen-
dix ﬁgure 3), and was repeated with the focus on AAU
(see online supplementary appendix ﬁgure 4). For this,
we convened a multidisciplinary team which included
senior clinical leaders, senior nurses, junior doctors, con-
sultant physicians, therapists, pharmacists and a data
analyst. All contributed to the mapping and development
of the interventions (see online supplementary appendix
ﬁgure 5). For example, the physiotherapists advised on
how they check a patient’s use of medication compliance
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aids, and occupational therapists on ﬁnding ‘old’ medi-
cines during home visits. Stakeholder engagement events
open to staff and public were held, and regular patient
focus groups around medicines management topics con-
tinued through to July 2012. Members of the public were
called on on an ad hoc basis at ﬁrst, and subsequently,
patient representatives were fully recruited to the core
team resulting in co-design of our interventions and
systems updates. An Action Effect Diagram was drawn with
contributions from all stakeholders and the overall aim
agreed (see online supplementary appendix ﬁgure 6).8
Plan Do Study Act (PDSA) cycles further informed the
project from the beginning and as it progressed (see
online supplementary appendix table 1).9 Stakeholders
received feedback through emails and personal communi-
cations when the process maps were ﬁnalised.
Interventions were agreed as the most likely to lead to
measurable improvements, assigned into one of three
work streams:
▸ education,
▸ documentation,
▸ communication out of hospital.
Analytic plans
The study was a qualitative and quantitative improve-
ment project using statistical process control (SPC) to
monitor improvement measures.
SPC analyses are a graphical family of techniques
designed for looking at data over time. SPC uses a
number of ‘rules’ to determine whether a process has
unusual variation (special causes), or if ﬂuctuations
observed are simply representative of the inherent prop-
erties of that process.10 In this study, we use the ﬂexible
XmR analysis and consider special causes to be indi-
cated by points falling outside the natural process limits;
a trend of six or more all increasing or decreasing
values, and seven or more points consecutively above or
below the mean line.11 Qualitative analysis of outputs
from workshops, focus groups and stakeholder events,
were undertaken as they took place throughout the
project. Themes emerging from the analyses, including
patients’ wish to have their own summary of new medi-
cines on discharge with a personalised list of side effects
(rather than the full medicine package information) in
plain language, were used to co-design the new style
Discharge Summary (DSUM) (see later, Interventions).
In addition, the early analysis helped form the structure
and content of staff education and induction sessions (see
later, Interventions).
Data collation was carried out each week by the
research pharmacist (SK). A sample of 10 discharge pre-
scriptions was identiﬁed weekly using randomly gener-
ated numbers. Checks were put in place to ensure that
no patient was included more than once; readmissions
were identiﬁed and noted (but not analysed for this
project). Data was obtained retrospectively from ePR and
dispensing records to identify any unintentional discrep-
ancies between the inpatient prescription chart and
discharge list of medicines. Conﬁrmation of pharmacist-
led veriﬁcation of a patient’s medication history was
obtained from documentation in the electronic
pharmaceutical care notes and the discharge summary
for admission and discharge, respectively.
Process measures were designed to monitor improve-
ments (see table 1).
An error was recorded if any medicine was ordered
that should have been stopped (including wrong medi-
cine) or if a dose, route, course length or formulation
was incorrect. An omission was any medicine left off the
TTO that should be entered as it is to be continued.
Any change from the veriﬁed admissions list of medi-
cines without explanation or monitoring requirement
was also considered an error.
Weekly analysis of these measures was facilitated through
the web improvement support for healthcare (WISH)
tool.12 The tool provides reports with SPC analyses, by cal-
culating the mean and respective upper and lower natural
process limits of the measures in question, tracked over
time. Results were fed back to the core project team weekly.
The improvement measures supported the iterative
changes during implementation process and the use of
PDSA cycles, also documented through the WISH soft-
ware. Several audits measuring standards of medicines
history taking and reconciliation of discrepancies were
undertaken during the study period and helped to
inform and support the project. Further details of QI
methodologies and outputs are given in the online sup-
plementary appendices.
Data were collected from patients discharged between
weeks starting 30 October 2011 and 17 February 2013
(70 weeks, with one missing week). A poststudy audit was
carried out using the same sampling method from 06 June
to 31 August 2014 (9 weeks), to check whether any
improvements made during the project were sustained.
Small variations in selected numbers occurred in-week
where there were delays in a patient’s discharge. These
patients were not excluded but appeared at a later date in
the measures data.
Interventions
All interventions took place during October 2011 to
February 2013. Further details are provided in the online
supplementary appendices.
Education
All pharmacists and medicines management technicians
received a training update and accreditation in medi-
cines reconciliation and were instructed in the import-
ance of full documentation of preadmission medication
histories. Feedback was provided on a regular basis, at
least twice monthly, advocating ‘good practice’ in sum-
marising changes made to medication during hospital-
isation. Training was held collaboratively with other staff
groups including nurses and therapists.
The team negotiated with AAU physicians to take a
10-min ‘Pharmacy session’ on AAU during the weekly
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‘learning at lunch’ for doctors. At these sessions, and
also at induction, around midyear changeover
(November/December and March/April), and before
end-of-year change ( July/August), a pharmacist
describes the principles of medicines reconciliation,
good prescribing and monitoring. They also advise on
timely administration of critical medicines, reviewing
and continuing regular medication, and how pharma-
cists support the processes involved.
Two junior doctor champions were recruited to assist
with the delivery of training and act as a channel for
providing feedback to their peers. The project cham-
pions were well received (informal feedback from
peers), and reported high levels of satisfaction with their
role (informally direct to the rest of the project team
and at appraisal with their clinical leads).
Documentation
ePR Provides an easily accessible central documentation
of patients’ current medication and relevant history
including what the patient actually takes, their allergies,
intolerances and preferences, on the same screen as
inpatient prescribing. This allows access to the original
list while prescribing so that changes made by the hos-
pital clinicians can be transcribed onto the discharge
documentation with ease. However, locally the medica-
tion history list and medicines reconciliation detail
required free-typing, without a set format or obligatory
ﬁelds. Following consultation with IT support and the
junior doctor champions, changes to the system were
designed by the project team and approved by the
executive lead for ePR, creating tools to prompt and aid
documentation of medication reconciliation. (These
were brought in during the project data collection
period in October 2012 as an intervention, so that we
are able to measure any effect on documentation and
communication) and included
▸ Changing screen colours to distinguish between
reconciled and unreconciled medication lists.
▸ Changing existing ‘Pharmacy Discharge Summary
Text’ box visible on GP, patient and pharmacy copy to
‘Pharmacy Screening/Dispensing Text’ only visible
on pharmacy copy. GPs and patients previously
received unnecessary dispensing information on their
discharge summary.
▸ Creating a ‘Pharmacy Medicines Management Text’
box, to allow clear timely documentation by pharma-
cists of medicines reconciliation, and information
about changes visible as required on all copies. This
includes conﬁrming where medicines reconciliation
was not completed at admission.
▸ The addition of space headed ‘Information for
Patient’ on the patient copy of the discharge summary
for the pharmacist to add selected counselling points
speciﬁc to their new medicines.
Table 1 Process measures
Measure
Measure in sample of 10 patients per week
randomly selected from all discharges for the
week Detail
1 Percentage of patients with pharmacist-verified
reconciliation on admission
Pharmacist has documented on ePR that they have checked
the admission medication list with the patient and verified
with a second source and clarified or resolved any
discrepancies on the inpatient order with the prescriber
2 Percentage of patients with pharmacist-verified
reconciliation at discharge out of the total number
of patients sampled
Reconciliation at discharge is possible only for patients with
a verified admissions medication list. For this measure, any
change to any admission medicine, dose, frequency or route
is confirmed by a pharmacist as intentional and documented
clearly on the discharge summary as such
3 Percentage of patients with error-free TTO
prescriptions
TTO has no unexplained discrepancy compared with the
verified list of medicines on admission. The reason is stated
for any omission, change in dose, frequency or route; course
lengths and monitoring advice are given where needed. If no
reason is given for a discrepancy then the patient does not
have an error-free prescription
4 Percentage of medications unreconciled at
discharge out of the total number of medicines
within the sample of 10 discharge summaries per
week
Measure 4 is directly related to measure 3. The number of
individual medicines unreconciled were recorded. Patients
on no medicines were included in the study; medicines
reconciliation was considered reliable only if ‘nil regular
medication’ was verified and documented as such
5 Percentage of medications with an error
(or omission) on TTO out of the total number of
medicines within the sample of 10 discharge
summaries per week
Measure 5 is directly related to measure 3. The number of
individual medicines with an error or omitted without
explanation were recorded. For each patient, several
medicines may be prescribed in error or omitted from the TTO
ePR, electronic prescribing system; TTO, take-home medicines
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▸ Signposting to the hospital medicines information
helpline to aid access to further information they may
need once they are home, developed in response to
patient experience feedback.13 14
Communication with the GP
At ﬁrst presentation at hospital, an individual patient’s
complete list of current medication is required either via
the patient or their carer (eg, a repeat prescribing docu-
ment or detail on a referral letter from the GP), or if
this is not with the patient, the GP surgery is usually con-
tacted at the earliest opportunity. There is as yet no
direct e-communication locally between the hospital
ePR and GP practices. We use the telephone to request
and fax to receive patient medication record details.
On transfer home, we create the discharge summary
including the TTO which is for many medicines, a
simple transfer from the inpatient ePR. A copy is
emailed or posted to the GP. Communication out to
the GP about any changes made to medication in
hospital requires free-typing into the discharge
summary; local audit found this was missing in over
40% of cases. The approved changes to the ePR docu-
mentation as above were designed to improve medica-
tion reconciliation communication, including with
the GP.
RESULTS
A step-wise improvement is seen across measures relating
to discharge medicines reconciliation throughout the
project (ﬁgures 1–4). For the poststudy audit, all mea-
sures indicate sustained improvement, summarised in
table 2.
During the study period, an average of 66.3% of
patients have pharmacist-veriﬁed medicines reconcili-
ation on admission (see ﬁgure 1A). A temporary uplift
in the process is observed starting in June 2012 with
seven points above the mean line, however, the process
reverts to previous performance levels after this period.
The average (mean) showed some short-term improve-
ment to 82.7% coinciding with when initiatives were put
in place to engage staff in pharmacist-led processes.
Reconciliation at discharge is possible only for those
who had a veriﬁed list of admission medicines.
Pharmacist documentation of medicines reconciliation
at discharge improved from an average of 26.2% of
patients to 56.7% (ﬁgure 1B). A single point outside the
natural process limits is observed in March 2012, indicat-
ing a special cause. From August 2012 onwards, all points
lie above the previous mean performance (special cause
variation), hence the natural process limits are calculated
separately for this period to better represent the
improved process. This improvement appears to be sus-
tained and improved on, as it was found during the
summer of 2014, that an average of 64.8% of discharged
patients had their medicines reconciled and documen-
ted on the discharge summary (table 2).
On 1 week with high bed pressures (31 May 2012, see
ﬁgure 2) performance was below average, recovering
over a 6-week period of increasing trend (constituting
an SPC rule break). There are two indications of special
cause with data lying beyond the natural process limits
in October 2012 and November 2012. The periods of
bed pressures did not appear to affect pharmacists’
admission activity.
The short-term improvement mid-project appears to
have been achieved 1 year on as it was found that
in a 9-week period of measures during summer
2014, an average of 88.1% of patients had
pharmacist-led medicines reconciliation documented
on admission.
After an initial low period, an average of 47.2% of
patients with no medication errors or omissions on dis-
charge is seen, but with marked variation in late 2012
coinciding with the changes being embedded in the
editable part of the discharge summary (ﬁgure 2). In
the period of measures during summer 2014, an
improvement was seen with 85.2% patients having
error-free medication using the same criteria for recon-
ciliation as during the project 18 months previously
(table 2).
Key events mapped onto the process control chart for
error-free medications from admission and through to
discharge during one calendar year of the project, show
the relationship between junior doctor rotations and the
weeks when the hospital was under bed pressures
(ﬁgure 2). A fall in the percentage of error-free medica-
tions is seen during September 2012 though this is not
sustained and improvements are apparent when teach-
ing sessions had been completed.
The average for medications unreconciled was 13.5%
(ﬁgure 3). There are three indications of special cause,
October 2011, September 2012 and October 2012. In
the summer of 2014, improvement was found with 3.7%
of medicines recorded as unreconciled at discharge
(table 2).
The percentage of medications with an error (or omis-
sion) was an average of 15.8% (ﬁgure 4). There are two
indications of special cause variation, September 2012
and October 2012. During summer 2014, improvement
was seen with an average of 2.3% of medicines (pre-
scribed or omitted) in error using the same criteria as
during the project (table 2). Note that in ﬁgures 3 and 4
there are transient uplifts in values, before reversion to
previous performance, across August and September 12;
the period in which newly qualiﬁed doctors begin their
training.
DISCUSSION
Hospital-based, pharmacist-led medicines reconciliation
processes frequently identify and resolve unintended
prescribing discrepancies between healthcare providers.1
We have made improvements to these local processes
particularly in provision of documentation and
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communication of medication changes at discharge
from hospital.
The effect of this QI is demonstrated in the decrease in
numbers of patients leaving hospital with unintentional
discrepancies (errors or omissions) on their discharge
prescription. Though there was marked variation in this
ﬁgure during the study, it appears to be sustained overall
with an expectation that it remains consistently below
20% (as shown in 2014). However, the period from
August to October in 2012 shows an increase in the
Figure 1 (A) (Measures 1: higher percentage preferred): percentage of patients with pharmacist-verified reconciliation on
admission. (B) (Measure 2: higher percentage preferred): percentage of patients with pharmacist-verified reconciliation at
discharge.
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number of unreconciled discrepancies in discharge med-
ications. We have looked for explanations for this as it
does not coincide with the hospital being particularly
busy or under pressure for beds or other parameters that
we were monitoring at the time. It may have been inﬂu-
enced by the period of high staff turnover in pharmacy
which occurs every new academic year. Though not the
project team per se, we were inducting new juniors and
managing unprecedented vacancies including staff leave
(postponed during the London Olympics and taken in
September and October that year).
There is clearly a need for further improvement;
regular teaching and support, particularly for junior
doctors, have been put in place, and remain a key aspect
of current practice and the subject of further medicines
optimisation research locally. In addition, the pharmacist
induction programme locally now includes training in
documentation of medicines reconciliation on ePR.
We found a high level of variation in the percentage
of patients with error-free discharge prescriptions, in
particular, around the time of introducing the changes
to processes on ePR. The changes required different
inputs by the prescriber, and though all were trained by
the implementation date, many had their training
several weeks before. Variations may also have been the
result of the small sample set for weekly measures. Ten
patients were selected each week. If a fully trained
‘good’ prescribing team were on duty for the sampling
period it could contrast with one less familiar with TTO
requirements on duty the following week.
Overall, our ePR updates appear to have had a positive
effect on the quality of discharge summaries, as error-
free TTO rates are seen to rise in the period from its
inception in October 2012 to February 2013 when meas-
urement stopped, and again when measured in 2014.
A median of 45% of hospital patients in the USA
and Canada have at least one clinically signiﬁcant dis-
crepancy in their medications at transfer of care
according to a systematic review of reconciliation in
2013.15 Garﬁeld and colleagues in the UK found unin-
tentional discrepancies in 70% of medication pre-
scribed on admission for around 60% of patients.16
Unintentional discrepancies in discharge medication
received by patients occurred in up to 27% of items,
and these translated to discrepancies in repeat medica-
tion subsequently received from the GP in 57%
patients.17 In our study, we looked at documentation
on the discharge summary exactly as it would be
received by the GP. An ‘error’ was recorded if a medi-
cine was missing from this communication, or if
details of a change in medication were not noted. The
number of medicines unreconciled at discharge fell to
10% and then to 4% (2014 ﬁgures). Ascertaining
whether any changes to medication reported are
Figure 2 (Measure 3: higher per cent preferred): percentage of patients with error-free (and no omitted) medications on TTO
prescriptions\r\nKey AAU, Acute Admissions Unit; DSUM, Discharge Summary; FY, foundation year junior doctors; ‘Lastword’:
the local EPR system.
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actually received and acted on by the recipient was
outside the scope of this project.
Follow-up of patients at another UK hospital where
medicines reconciliation was found to be incomplete
revealed that the majority of failures occur when the
standard admission documentation is not used. This was
more likely to occur where specialist admission pathways
were in place and paper pro formas were not updated,
or if they had to be used in parallel with several other
documents.17 A survey of pharmacy services for patients
at discharge from hospitals in Ireland suggested that
development of national standards of practice may help
to eliminate the variation found in practice and would
support improvement.18 During our study, we embedded
new ePR tools to prompt and aid documentation of
medication reconciliation particularly on the discharge
Figure 4 (Measure 5: lower per cent preferred): the percentage of medications with an error or omission on TTO.
Figure 3 (Measure 4: lower per cent preferred): the percentage of medications unreconciled at discharge.
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summary. In addition, at admission, we sought to stand-
ardise the pharmaceutical care entries made by phar-
macy staff regarding medication histories. An audit
undertaken in 45 English hospitals (including this study
site) suggests that pharmacist-led medicines reconcili-
ation at admission prevents adverse events occurring
during an inpatient stay.19
In the 2013 systematic review, the authors note that
the actual beneﬁts of resolving unintended discrepan-
cies are not seen; medicines reconciliation does not
seem to reduce emergency department visits or readmis-
sion within 30 days. The reviewers found that most medi-
cation discrepancies appeared to have no clinical
signiﬁcance and, given limited resources in hospitals, it
is suggested it may be prudent to target patients at high
risk rather than all admissions.15 Our study did not
include patient follow-up, so does not add to this, but
follow-on projects are planned where we will target vul-
nerable patients (especially elderly) identiﬁed through
medicines reconciliation and other processes for further
pharmacist intervention with examination of the clinical
signiﬁcance of intervening on unintentional discrepan-
cies and readmission rates.
In part, to inform this research, we recently compared
medicines reconciliation by doctors on ﬁrst contact with
patients to pharmacy-veriﬁed medication lists. Full and
accurate documentation was found for only 27% of
patients prior to pharmacy check. The value of the
pharmacist in medicines reconciliation was also shown
in a Swedish medical ward though the researchers sug-
gested more work is needed.20
Documentation by pharmacists of medicines reconcili-
ation at discharge in addition to that undertaken on
admission was a new concept locally. We have now inte-
grated the process into the patient-centred pharmaceut-
ical care carried out by our team of clinical (ward)
pharmacists as part of their regular duties. All inpatient
prescriptions are reviewed by a pharmacist at the ﬁrst
opportunity, including medicines reconciliation within
24 hours of admission where possible. It is a challenge at
weekends where stafﬁng levels are lower; currently
under review locally and across the UK. The changes we
have put in place around discharge reconciliation have
been achieved without extra resources but with critical
refocussing of pharmacist input. Prior to this project,
any changes made to patients’ medicines had to be com-
municated by the prescriber as part of the free-type
letter to the GP on the discharge summary.
There appears to be a relationship between quality
of discharge summary and junior doctor rotations.
Interventions speciﬁcally made at key times in rotations
to improve discharge summary documentation appear
to have a positive effect on the number of patients with
error-free TTOs.
We recognised the importance of organisation and
structure in reducing unintended discrepancies at trans-
fer of care. A ‘whole system’ approach in this discharge
process involved members of staff from a range of disci-
plines, all of whom were involved in appropriate pre-
scribing, ensuring the assessment of a patient’s ability to
take their medication, or education of a patient about
their discharge medications. While other studies have
underlined the importance of the interactions between
medical and pharmacy staff, the success of this project
partly lay in its ability to engage with nursing and allied
health staff in addition.
The project team made ongoing sustainability a prior-
ity from the start, which is judged as important in
embedding change,21 and where appropriate, systems
change was sought (eg, improved electronic prescribing
software functionality). Building improvements into the
processes helps to minimise human error and reduce
variability of outcomes. Better use of existing resources,
and embedding new tools for daily practice therein,
ensures a sustainable change for the organisation which
might be expected to be cost-neutral.
Integration of best practice project management using
QI methods ensured a clear structure to the project
organisation and management, while allowing room for
creativity.
LIMITATIONS AND LESSONS LEARNT
We were unable to show if our improvements in commu-
nication out of hospital had any impact postdischarge.
This will be the subject of future project work in the
community. The data presented here suggests a link
between pharmacist involvement and a decrease in
errors, but is not conclusive. We were not able to
examine for secular trend as there are no prior data or
further sites; we recommend a step-wedge design for any
scale-up initiative to allow comparisons.
The project team was successful in engaging and in-
ﬂuencing staff from all levels in changing practice.
Communication barriers with doctors where they existed
were removed with the recruitment of junior doctor
Table 2 Audit data to examine for sustainability of changes
For audit period: weeks starting 6 July 2014 to 31 August 2014
Number of patients in audit=88, number of medications=1148, mean number per patient=13
% Patients with
pharmacist-verified
reconciliation on admission
% Patients with
pharmacist-verified
reconciliation at discharge
% Patients with
error-free
medication
% Medications
unreconciled at
discharge
% Medications
in error
87.5 64.8 85.2 3.7 2.3
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champions to deliver training and provide feedback to
peers. Culture within the pharmacy department was
changed by seeking out early adopters to act as catalysts
for change. Engaging the right people at the right time
for the right tasks that complement their skills and in-
terests, was a key to success (eg, AAU sister in mapping
discharge process; junior doctors in preparing posters).
This included effective engagement with the hospital’s
GP Relationships Manager who supported the project’s
initiatives where possible; this proved important, as
engaging directly with GPs was difﬁcult.
Other aspects of the project, such as junior doctor
and patient education, which are labour intensive, were
successful but may prove less sustainable.
RECOMMENDATIONS
Regular feedback of the quality of doctor’s medication
reconciliation at discharge is an important aspect of
training that has resulted in an improvement in the
number of patients discharged without errors on the dis-
charge summary. However, maintaining weekly measures
to allow such feedback is very time consuming. An
option could be through incorporating the weekly mea-
sures into Trust clinical audit agenda.
The data in the current form are unable to distin-
guish whether the improvement in number of unrec-
onciled medicines or number of errors is because of
the introduction of pharmacist discharge medicines
reconciliation and documentation. We do not know if
they resulted in improved patient outcomes nor if
communications in the discharge summaries are
actioned by the recipient. We therefore recommend
that a subset analysis and follow-up is carried out to
compare outcomes for patients who have had pharma-
cist involvement in the preparation of the discharge
summary.
CONCLUSION
During the period of our medicines reconciliation
project we put in place new processes that led to a sus-
tained reduction in unreconciled medications and,
thereby, an improvement in the number of patients
whose discharge medications were documented and
communicated out from the hospital without error or
omission. The initiatives were pharmacist-led but
involved close working and shared understanding about
roles and responsibilities between doctors, nurses and
patients or their carers.
Care has been taken to embed the processes involved
into standard working practices and computerised
systems, ensuring that reliable reconciliation and docu-
mentation is sustainable.
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